Humphries Romney M
Department of Pathology and Laboratory Medicine, University of California, Los Angeles, California; Clinical Microbiology, UCLA Health System, Los Angeles, California.
Pharmacotherapy. 2015 Jan;35(1):22-7. doi: 10.1002/phar.1505. Epub 2014 Oct 20.
Antimicrobial susceptibility testing for the polymyxins-colistin and polymyxin B-is fraught with technical challenges. Key among these is the propensity of the polymyxins to adsorb to polystyrene, a material often used for in vitro minimum inhibitory concentration testing devices. This effect may be mitigated by the addition of a surfactant such as polysorbate 80; however, concern exists that polysorbate 80 may act synergistically with the polymyxins and artificially lower minimum inhibitory concentrations. Furthermore, the polymyxins diffuse poorly through agar, compromising the performance of both disk diffusion and Etest methods. Very few peer-reviewed studies have investigated in vitro susceptibility test methods for the polymyxins, and it is clear that an in vitro test that reliably predicts the activity of the polymyxins in vivo has yet to be defined. This review describes the methods available and challenges associated with susceptibility testing of colistin and polymyxin B and discusses the current breakpoints for both agents.
对多粘菌素(黏菌素和多粘菌素B)进行药敏试验存在诸多技术挑战。其中关键的一点是,多粘菌素易于吸附到聚苯乙烯上,而聚苯乙烯是常用于体外最低抑菌浓度检测设备的一种材料。添加诸如聚山梨酯80之类的表面活性剂或许可以减轻这种影响;然而,人们担心聚山梨酯80可能会与多粘菌素产生协同作用,从而人为降低最低抑菌浓度。此外,多粘菌素在琼脂中的扩散性较差,这会影响纸片扩散法和Etest法的检测性能。很少有经过同行评审的研究对多粘菌素的体外药敏试验方法进行过调查,而且很明显,一种能够可靠预测多粘菌素体内活性的体外试验方法尚未确定。这篇综述描述了现有的检测黏菌素和多粘菌素B药敏的方法以及相关挑战,并讨论了这两种药物目前的折点。